Exo Imaging is developing an affordable, diagnostic-grade handheld ultrasound platform that combines patented Piezoelectric Micromachined Ultrasonic Transducers (pMUT) technology, advanced signal processing, and AI for imaging and therapeutic applications. The device aims to deliver exceptional image fidelity, penetration depth and 3D imaging while fitting in the palm of a clinician’s hand. The company emphasizes reducing cost through semiconductor-scale manufacturing and novel sensor and nano-material advances. Exo’s mission is to expand access to high-quality medical imaging by improving economics, usability, and accessibility for a broad set of users. The company plans to advance its products through the FDA 510K clearance process and into commercialization, while building out engineering, sales, and operations teams. Founded leadership includes Sandeep Akkaraju (CEO), Janusz Bryzek (chairman and chief visionary officer), Yusuf Haque (CTO), and John Kokulis (CFO).

Total raised

$35M

Funding rounds

1

Latest round

Series B

Latest activity

Aug 2019